Results 171 to 180 of about 35,587 (246)

Drug Repurposing for AML: Structure-Based Virtual Screening and Molecular Simulations of FDA-Approved Compounds with Polypharmacological Potential. [PDF]

Biomedicines
Abdelsayed M, Boulaamane Y.
europepmc   +1 more source

IDH1 NP_005887.2:p.R132H [PDF]

, 2020
openaire   +1 more source

IDH mutations are rare events in SHH medulloblastoma. [PDF]

Acta Neuropathol
Fürst A, Ruf V, Fiedler C, Rutkowski S, Sill M, Korshunov A, Gerber NU, Frank S, Hench J, Schüller U.   +9 more
europepmc   +1 more source

Supplemental Information from Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer Cells

, 2023
Mahsa Zarei, Shruti Lal, Seth J. Parker, Avinoam Nevler, Ali Vaziri‐Gohar, Katerina Dukleska, Nicole C. Mambelli‐Lisboa, Cynthia Moffat, Fernando F. Blanco, Saswati N. Chand, Masaya Jimbo, Joseph A. Cozzitorto, Wei Jiang, Charles J. Yeo, Eric Londin, Erin L. Seifert, Christian M. Metallo, Jonathan R. Brody, Jordan M. Winter   +18 more
openalex   +1 more source

IDH1 NP_005887.2:p.R132X [PDF]

, 2020
openaire   +1 more source

Olutasidenib: an Achilles' heel for IDH1-mutated MDS? [PDF]

Blood Adv
Wiser L, Lachowiez C.
europepmc   +1 more source

STMO-13 PATHOLOGICAL EVALUATION AND ONCOLOGICAL OUTCOME OF FLAIRECTOMY IN PATIENTS WITH IDH1 WILD-TYPE GLIOBLASTOMA

, 2022
Seiichiro Hirono, Yusuke Kouchi, Takashi Kishimoto, Masayoshi Kobayashi, Tomoo Matsutani, Yasuo Iwadate   +5 more
openalex   +1 more source

Molecular abnormalities and clinical features in adult patients with acute myeloid leukemia in Thailand. [PDF]

Diagn Pathol
Chantrathammachart P, Jinawath A, Puavilai T, Arsa L, Police P, Noikongdee P, Phojanasenee T, Sae-Lim P, Piyajaroenkij T, Choksomnuk P, Chuncharunee S, Niparuck P.   +11 more
europepmc   +1 more source

IDH1 wt Allele [PDF]

, 2020
openaire   +1 more source

Utility of IDH1/2 mutations as biomarkers for detection of measurable residual disease in acute myeloid leukemia. [PDF]

Blood Adv
Boertjes EL, Vonk CM, Kavelaars FG, Engvall M, Nordin S, Beugelink L, Rijken M, Konijnenburg JML, Versluis J, Löwenberg B, Valk PJM.   +10 more
europepmc   +1 more source